Biotech · Private company · Glen Rock, NJ, US
RespireRx Pharmaceuticals Inc.
SEC CIK 0000849636
Track this companyFree. Adds RespireRx Pharmaceuticals Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
SEC filings1
NIH awards2
- Development of a novel, preferring potentiator of GABAA receptor for treatment of epilepsyFiscal year 2026 · $1.5MNIH RePORTER 5R44NS143576-02 · fetched Nov 12, 2026
- Development of a novel, preferring potentiator of GABAA receptor for treatment of epilepsyFiscal year 2025 · $1.5MNIH RePORTER 1R44NS143576-01 · fetched Nov 12, 2026